Skip to main content
CriticalFDAfda-F-1831-2017LISTERIA

Premo Signature Classic Italian, 1/6 oz.

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
429
Recall Date
February 21, 2017
Issuing Agency
Hazard
Listeria

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1831-2017.

JLM Manufacturing initiated a recall on 02/21/2017 of multiple ready to eat sandwiches containing cheese because of a supplier's recall of cheese due to Listeria monocytogenes.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1831-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Lipari Foods, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1831-2017.

Lipari Foods, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Lipari Foods, Inc. Recall FAQ

Lipari Foods, Inc. is the subject of a food safety report: Premo Signature Classic Italian, 1/6 oz.. The notice was published on February 21, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 429 units are potentially affected.